Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

AZ’s Imfinzi hits second major milestone at Phase 3 in unresectable lung cancer

May 25, 2018 Medical Communications, Research and Development AstraZeneca, Imfinzi, NSCLC, lung cancer, pharma

AstraZeneca and its global biologics R&D MedImmune have lifted the curtain on new Phase 3 data for their immunotherapy Imfinzi …
News
john_crowley_edit

John Crowley speaks on drug development and the FDA

May 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amicus Therapeutics, John Crowley, biotech, drugs, pharma, pharmaceutical

Pharmafocus spoke to John Crowley, CEO of Amicus Therapeutics, about his highly unusual career in the pharmaceutical and biotech industries.
Feature
merck_and_co

MSD’s Keytruda scores impressive first-line lung cancer data

May 24, 2018 Research and Development, Sales and Marketing MSD, biotech, drugs, keytruda, pharma, pharmaceutical

MSD Keytruda has enjoyed the most success of the PD-1/L1 therapies in clinical trials recently and it’s rapidly cementing its …
News
handshake_2

Vifor Fresenius snap up rights to Cara’s itch therapy

May 23, 2018 Research and Development, Sales and Marketing Cara Therapeutics, Vifor Fresenius, biotech, drugs, pharma, pharmaceutical

The joint partnership between Vifor Pharma and Fresenius Medical Care, Vifor Fresenius, has put down $50 in upfront cash and …
News
fda2outsideweb

Sun Pharma drug combo scores FDA approval in advanced castration-resistant prostate cancer

May 23, 2018 Research and Development, Sales and Marketing Cancer, Churchill Pharmaceuticals, FDA, Sun Pharma, US, Yonsa, pharma, prostate cancer

Sun Pharma is celebrating with the announcement that its CYP17 inhibitor Yonsa (abiraterone acetate) has been awarded FDA approval in …
News
obese-3011213_960_720

World heading towards 25% of total population being obese

May 23, 2018 Research and Development WHO, biotech, drugs, obesity, pharma, pharmaceutical

The latest global research paints a bleak picture of future global public health, predicting that almost a quarter of the …
News
512px-kratom_leaves_3

FDA reprimands suppliers of opioid substitute kratom products

May 23, 2018 Research and Development, Sales and Marketing FDA, kratom, opioid crisis, opioids, pharma

The ongoing opioid epidemic in the US has seen the rise of the sale and use of kratom (mitragyna speciose), …
News
takeda_tokyo_hq

Takeda begins to shore up finances with $280m divestment

May 23, 2018 Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical

Much has already been written about Takeda and its massive financial stretch to pull in the Shire acquisition, in the …
News
640px-hiv-budding-color

India, Sweden and The Netherlands form HIV/AIDS research partnership

May 22, 2018 Manufacturing and Production, Research and Development AIDS, HIV, India, Sweden, The Netherlands, pharma

A first-of-its-kind collaboration has been announced by the governments of India, Sweden and The Netherlands with the goal of advancing …
News
brothers-457237_960_720

The cause of the most common form of childhood cancer found

May 22, 2018 Manufacturing and Production, Research and Development biotech, drugs, leukaemia, pharma, pharmaceutical

Professor Mel Greaves, of The Institute of Cancer Research, has spent 30 years uncovering what is behind the mysterious rise …
News
shutterstock_349943306

Clinical trials, Brexit and the question of ‘full alignment’

May 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit, clinical trials, feature, pharma

Gene Matthews, Partner at Leigh Day, reviews the tough decisions the UK has to make regarding its position in the …
Feature
european_commission_web

EMA review confirms risks of Abbvie and Biogen’s Zinbryta outweigh benefits

May 21, 2018 Research and Development, Sales and Marketing EMA, Europe, European Commission, PRAC, multiple sclerosis, pharma, zinbryta

The EMA has judged that the benefits offered by Zinbryta (daclizumab), Abbvie and Biogen’s humanised IgG1 monoclonal antibody for the …
News
roche

Roche’s Hemlibra stakes claim to be haemophilia market leader

May 21, 2018 Research and Development, Sales and Marketing Hemlibra, Roche, Shire, biotech, drugs, haemophilia, pharma, pharmaceutical

Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, Novartis, Takeda, Trump, brexit, pharma, pharmafile, top ten

The year is flying by – it’s another Friday, and that means another Top Ten run-down.Perhaps the biggest story this …
News

Pfizer’s Lyrica achieves endpoint as adjunct in paediatric epilepsy

May 18, 2018 Medical Communications, Research and Development FDA, Lyrica, Pfizer, epilepsy, pharma

Pfizer has revealed new Phase 3 data for its oral epilepsy therapy Lyrica (pregbalin) as an adjunctive treatment for partial …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026